# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-011883
Filing Date
2025-08-13
Accepted
2025-08-13 08:30:15
Documents
4
Period of Report
2025-08-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm | DEF 14A | 488882
2 | GRAPHIC | logo_001.jpg | GRAPHIC | 12748
3 | GRAPHIC | proxy_001.jpg | GRAPHIC | 499016
4 | GRAPHIC | proxy_002.jpg | GRAPHIC | 379126
| Complete submission text file | 0001493152-25-011883.txt |  | 1717301

Mailing Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET, SUITE 300 VERO BEACH FL 32960 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39531 | Film No.: 251209087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)